Kymera Therapeutics, Inc.
← Back to KYMR Overview

Kymera Therapeutics, Inc. (KYMR)

Revenue & Top-Line Growth

Latest Revenue

$34.4M

Financial Fundamentals

KYMRQuarterly Data • 5Y View

Historical Revenue Data

Quarterly Revenue Breakdown

DateRevenue ($B)QoQ %YoY %TTM ($B)TTM %
2026-03-310.03B+1101.6%+55.5%0.05B-12.6%
2025-12-310.00B+3.5%-61.3%0.04B-16.7%
2025-09-300.00B-75.9%-26.1%0.04B-50.1%
2025-06-300.01B-48.1%-55.3%0.04B-49.5%
2025-03-310.02B+198.9%+114.8%0.06B-25.8%
2024-12-310.01B+97.6%-84.6%0.05B-40.1%
2024-09-300.00B-85.4%-20.9%0.09B+86.9%
2024-06-300.03B+149.3%+55.3%0.09B+71.4%
2024-03-310.01B-78.5%+8.7%0.08B+70.2%
2023-12-310.05B+912.8%+196.7%0.08B+67.8%
2023-09-300.00B-71.4%-50.5%0.05B+1.9%
2023-06-300.02B+74.4%+43.4%0.05B-8.9%
2023-03-310.01B-41.3%-1.6%0.05B-26.8%
2022-12-310.02B+69.0%+5.7%0.05B-35.7%
2022-09-300.01B-17.0%-53.0%0.05B-34.7%
2022-06-300.01B+19.7%-37.8%0.06B-12.1%
2022-03-310.01B-37.0%-48.6%0.06B+29.3%
2021-12-310.02B-24.9%+19.5%0.07B+114.0%
2021-09-300.02B+9.8%+39.9%0.07B+204.7%
2021-06-300.02B-1.0%+463.2%0.06B+579.4%
2021-03-310.02B+46.3%+445.6%0.05B
2020-12-310.01B-12.0%+597.5%0.03B
2020-09-300.01B+342.0%+1429.8%0.02B
2020-06-300.00B-4.1%0.01B
2020-03-310.00B+87.0%0.00B
2019-12-310.00B+92.9%0.00B
2019-09-300.00B0.00B

Annual Revenue

YearTotal Revenue ($B)Growth %
20250.04B-16.7%
20240.05B-40.1%
20230.08B+67.8%
20220.05B-35.7%
20210.07B+114.0%
20200.03B+1060.0%
20190.00B
20180.00B